Organized by the Government of the Netherlands, Asociación Bienestar y Desarollo (Energy Control), the Global Drug Policy Observatory and the International Drug Policy Consortium Anke ter Hoeve, Netherlands: The Netherlands is a staunch supporter of evidence based drug policymaking. We had a side event on the matter and submitted a resolution which commanded great support. …
Side Event: Drug Crypto Markets Beyond 2020: Policy, Enforcement, Harm, and Resilience
Organized by the Netherlands, and Asociacion Bienestar y Desarollo (Energy Control), Global Drug Policy Observatory and International Drug Policy Consortium. Surprisingly little research on drug crypto markets. Crypto markets continue to function despite high profile law enforcement actions. Data suggests that production of drugs on crypto markets remain robust and in some contexts are increasing. …
Side Event- East African Community Regional Policy on Prevention, Management and Control of Alcohol, Drugs and Other Substances
Chair: We will discuss drug policy from the perspective of health, and East African Drug Policy. The African plan of action was developed last year. African communities are supportive of the comprehensive approach to drugs. but how are we going to contextualise them? Kunal Naik: We created the African Plan of action in 2018 in Cairo and finalised …
Side Event: Heroin and Ibogaine Assisted Treatments in the Era of the Opioids Crisis
Organized by European Coalition for Just and Effective Drug Policies and Nonviolent Radical Party Transnational Transparty Enrico Fletzer Pagan religion in Gabon – ibogaine was found by problematic heroin user and wake up with no need to take heroin anymore. Already people here at CND that’ve done this. But it’s quite complex Dr Chris Hallam, …
Side Event: Exploring the regulation of Cannabis markets in Latin America
Organized by Centro de Estudios Legales y Sociales, Elementa DDHH, México Unido Contra la Delincuencia and Washington Office on Latin America Lisa Sanchez, Mexico United against Crime (MUCD): Will discuss Mexico. Introduce what brought us here, what is happening currently with legislative discussions, and what are characteristics of the last bill that is likely to pass …
Committee of the Whole (Thursday afternoon) L4. Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes and improving their rational use
Chair: We still have two small issues. Belgium: After the informals where we discussed in length PP9 and OP2 we think that both paras seem to come as a package deal. So for OP2 we stay with “all existing barriers, [including those related to legislation, regulatory systems, health care systems, affordability, the training of healthcare …